VIVA GOLD CORP (VAU.CA) Fundamental Analysis & Valuation

TSX-V:VAU • CA92852M1077

Current stock price

0.145 CAD
-0.01 (-3.33%)
Last:

This VAU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. VAU.CA Profitability Analysis

1.1 Basic Checks

  • VAU had negative earnings in the past year.
  • VAU had a negative operating cash flow in the past year.
  • VAU had negative earnings in each of the past 5 years.
  • In the past 5 years VAU always reported negative operating cash flow.
VAU.CA Yearly Net Income VS EBIT VS OCF VS FCFVAU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -134.24%
ROE -168.74%
ROIC N/A
ROA(3y)-166.64%
ROA(5y)-147.23%
ROE(3y)-223.7%
ROE(5y)-195.97%
ROIC(3y)N/A
ROIC(5y)N/A
VAU.CA Yearly ROA, ROE, ROICVAU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

  • VAU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VAU.CA Yearly Profit, Operating, Gross MarginsVAU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. VAU.CA Health Analysis

2.1 Basic Checks

  • VAU has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VAU has more shares outstanding
  • There is no outstanding debt for VAU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VAU.CA Yearly Shares OutstandingVAU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
VAU.CA Yearly Total Debt VS Total AssetsVAU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M

2.2 Solvency

  • VAU has an Altman-Z score of 15.95. This indicates that VAU is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for VAU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.95
ROIC/WACCN/A
WACCN/A
VAU.CA Yearly LT Debt VS Equity VS FCFVAU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M

2.3 Liquidity

  • A Current Ratio of 18.75 indicates that VAU has no problem at all paying its short term obligations.
  • VAU has a Quick Ratio of 18.75. This indicates that VAU is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 18.75
Quick Ratio 18.75
VAU.CA Yearly Current Assets VS Current LiabilitesVAU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. VAU.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.47% over the past year.
EPS 1Y (TTM)6.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. VAU.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VAU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VAU.CA Price Earnings VS Forward Price EarningsVAU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VAU.CA Per share dataVAU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VAU.CA Dividend Analysis

5.1 Amount

  • No dividends for VAU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VAU.CA Fundamentals: All Metrics, Ratios and Statistics

VIVA GOLD CORP

TSX-V:VAU (3/31/2026, 7:00:00 PM)

0.145

-0.01 (-3.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-18
Earnings (Next)N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins Owners2.2%
Ins Owner ChangeN/A
Market Cap24.95M
Revenue(TTM)N/A
Net Income(TTM)-2.61M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 16.14
P/tB 16.14
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -134.24%
ROE -168.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-166.64%
ROA(5y)-147.23%
ROE(3y)-223.7%
ROE(5y)-195.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 18.75
Quick Ratio 18.75
Altman-Z 15.95
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.93%
OCF growth 3YN/A
OCF growth 5YN/A

VIVA GOLD CORP / VAU.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for VIVA GOLD CORP?

ChartMill assigns a fundamental rating of 2 / 10 to VAU.CA.


What is the valuation status for VAU stock?

ChartMill assigns a valuation rating of 0 / 10 to VIVA GOLD CORP (VAU.CA). This can be considered as Overvalued.


What is the profitability of VAU stock?

VIVA GOLD CORP (VAU.CA) has a profitability rating of 0 / 10.


What is the financial health of VIVA GOLD CORP (VAU.CA) stock?

The financial health rating of VIVA GOLD CORP (VAU.CA) is 6 / 10.